Old Web
English
Sign In
Acemap
>
authorDetail
>
Elmar Wimmer
Elmar Wimmer
Merck KGaA
Pharmacology
Biochemistry
Chemistry
Metabolite
In vivo
5
Papers
42
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Metabolism of the MEK1/2 Inhibitor Pimasertib Involves a Novel Conjugation with Phospho-Ethanolamine in Patients with Solid Tumors
2017
Drug Metabolism and Disposition
Holger Scheible
Friedrich Kraetzer
Andreas Marx
Andreas Johne
Elmar Wimmer
Show All
Source
Cite
Save
Citations (5)
Absolute bioavailability, mass balance, elimination route, and metabolite profile of the selective oral MEK1/2 inhibitor pimasertib in cancer patients.
2014
Journal of Clinical Oncology
Giorgio Massimini
Istvan Udvaros
Elmar Wimmer
Oliver von Richter
Andreas Johne
Show All
Source
Cite
Save
Citations (1)
Comparison of the in vitro and in vivo metabolism of Cladribine (Leustatin, Movectro) in animals and human
2013
Xenobiotica
Holger Scheible
Marc Laisney
Elmar Wimmer
Ana Javornik
Hugues Dolgos
Show All
Source
Cite
Save
Citations (7)
In vitro characterization of sarizotan metabolism: hepatic clearance, identification and characterization of metabolites, drug-metabolizing enzyme identification, and evaluation of cytochrome p450 inhibition.
2010
Drug Metabolism and Disposition
Dieter Gallemann
Elmar Wimmer
Constance C. Höfer
Achim Freisleben
Markus Fluck
Bernhard Ladstetter
Hugues Dolgos
Show All
Source
Cite
Save
Citations (6)
Species Differences in the Response of Liver Drug-Metabolizing Enzymes to (S)-4-O-Tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric Acid (EMD 392949) in Vivo and in Vitro
2008
Drug Metabolism and Disposition
Lysiane Richert
Gregor Tuschl
Catherine Viollon-Abadie
Nadège Blanchard
Alexandre Bonet
Bruno Heyd
Nermin Halkic
Elmar Wimmer
Hugues Dolgos
Stefan O. Mueller
Show All
Source
Cite
Save
Citations (23)
1